SurModics (SRDX) Misses Q2 EPS by 1c, Revenues Beat; Offers FY21 EPS Guidance Below Consensus, FY21 Revs. Mid-Point View Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
Go back to SurModics (SRDX) Misses Q2 EPS by 1c, Revenues Beat; Offers FY21 EPS Guidance Below Consensus, FY21 Revs. Mid-Point View Above Consensus
April 28, 2021 3:59 PM EDT
Needham & Company analyst Mike Matson raised the price target on SurModics (NASDAQ: SRDX) to $68.00 (from $61.00) while maintaining a Buy rating.
The analyst commented, "SRDX F2Q21 revenue and EPS beat consensus. Revenue growth improved to 53.3% in F2Q21 from (1.4%) in... More
